# Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

> **NCT03771651** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 18 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Fallopian Tube Infection

## Interventions

- **DRUG:** Aspirin 81 mg

## Key facts

- **NCT ID:** NCT03771651
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2022-05-06
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771651, "Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03771651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*